Type
. Identification of two new loci at IL23R and RAB32 that influence susceptibility to leprosy. Nature genetics. 2011;43(12):1247-51.
Type
. Leprosy in the Bible. Clinics in dermatology. 2016;34(1):3-7.
Type
. Leprosy: Social implications from antiquity to the present. Clinics in dermatology. 2016;34(1):8-10.
Type
. Leprosy as a multilayered biosocial phenomenon: The comparison of institutional responses and illness narratives of an endemic disease in Brazil and an imported disease in Portugal. Clinics in dermatology. 2016;34(1):16-23.
Type
. Epidemiologic trends of leprosy for the 21st century. Clinics in dermatology. 2016;34(1):24-31.
Type
. History of chemotherapy of leprosy. Clinics in dermatology. 2016;34(1):32-36.
Type
. Leprosy type 1 reaction (formerly reversal reaction). Clinics in dermatology. 2016;34(1):37-50.
Type
. Assessing nerves in leprosy. Clinics in dermatology. 2016;34(1):51-58.
Type
. Growth, and Development of Care for Leprosy Sufferers Provided by Religious Institutions from the First Century AD to the Middle Ages [Internet]. University of South Florida; 2016. Available from: http://scholarcommons.usf.edu/cgi/viewcontent.cgi?article=7517&context=etd
Type
. Level of public awareness on leprosy and its effects on leprosy control programmes in Anambra and Ebonyi States of Southeast Nigeria. American Journal of Research Communication [Internet]. 2015;3(8):67 - 93. Available from: http://www.usa-journals.com/wp-content/uploads/2015/07/Nwankwo_Vol38.pdf